oral semaglutide fda Gets Approval for CV Event Reduction in High-risk Diabetes Patients FDA Approves Weight Loss Drug

Per publicly available FDA and manufacturer announcements, the Wegovy pill (once-daily oral semaglutide 25mg) received FDA approval on December 22, 2025 and launched broadly across US pharmacies in January 2026 - the first oral GLP-1 receptor agonist approved for chronic weight management

AHK-Cu 200mg AHK-Cu is a peptide with a copper ion linked to it

Phatak, N

I had gotten in with my eyes open that this was a high risk high reward play, but I was concerned that I hadnt conveyed that clearly enough in the article

From fiber myths to vitamin C, in this letter you will meat 8 myth about the dietand why they may not be as clear-cut as you think